Pharmacists in North Little Rock, Arkansas
108 Pharmacists found in North Little Rock
Dr. Randy Issa Kassissieh, PHARMD
Pharmacist
4307 E Broadway St, North Little Rock, AR 72117
501-945-3264 501-945-6976
Mrs. Rebecca Ann Renick, DOCTOR OF PHARMACY
Pharmacist
4307 E Broadway St, North Little Rock, AR 72117
501-945-3264 501-945-6976
Rena Michelle Lacheen, PHARMD
Pharmacist
2200 Fort Roots Dr, Bld 66 Rm 152, North Little Rock, AR 72114
501-257-3348
Dr. Sara J Hill, PHARMD
Pharmacist
5328 Jfk Blvd, North Little Rock, AR 72116
501-246-5035 501-246-5448
Dr. Sarah Nicole Young, PHARMD
Pharmacist
4401 Camp Robinson Rd, North Little Rock, AR 72118
501-758-6360
Dr. Sharon Denise Powell, P.D.
Pharmacist
2500 Mccain Blvd, North Little Rock, AR 72116
501-812-6228 501-812-5739
Dr. Shelly M Spollen, PHARMD
Pharmacist - Psychiatric
2200 Fort Roots Dr, North Little Rock, AR 72114
501-257-3175
Dr. Sherrie L Lane, PD - PHARMACIST
Pharmacist
2200 Fort Roots Dr, North Little Rock, AR 72114
501-257-1000
Dr. Sonia Deloach Johnson, PHARMD
Pharmacist
2200 Fort Roots Dr, North Little Rock, AR 72114
501-257-1000
Mrs. Susan Renee Briggler, PHARMD
Pharmacist
4823 Jfk Blvd, North Little Rock, AR 72116
501-771-1971
Tabita Peret Secrian, PHARM.D.
Pharmacist - Geriatric
760 Michaela Dr, North Little Rock, AR 72117
501-992-1006
Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.